AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Trial: 18848765
Drug: Intramuscular (IM)
RxNorm normalized name: intramuscular immunoglobulin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intramuscular (IM) Acthar Gel (80 units)
Trial: 17449974
Drug: Er,Cr:YSGG laser
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Er,Cr:YSGG laser therapy combined with SRP
Trial: 11122543
Drug: Argatroban (100
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Argatroban (100 microg/kg bolus plus 3 microg/kg/min infusion for 72 hours)
Trial: 11122543
Drug: Heparin (5000
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Heparin (5000 U intravenous bolus, 1000 U/h infusion)
Trial: 9352988
Drug: Chronic vasodilator
RxNorm normalized name: Chromic Chloride
DrugBank: Chromic chloride (DB09129)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Chronic vasodilator therapy
Trial: 9352988
Drug: Discontinuation of
RxNorm normalized name: OIL OF CAMPHOR
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Discontinuation of vasodilators
Trial: 8441105
Drug: Procedure A
RxNorm normalized name: hydrocortisone
DrugBank: Hydrocortisone succinate (DB14545)
FDA approved: yes
EMA approved: yes
PMDA approved: no
Description: Procedure A (two fractional doses after removal from ventilator)
Trial: 8441105
Drug: Procedure B
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Procedure B (two fractional doses through a neonatal suction valve without removal from ventilator)
Trial: 8441105
Drug: Procedure C
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Procedure C (four fractional doses during removal from ventilator)
Trial: 28259274
Drug: Routine injection
RxNorm normalized name: Peace Out Acne Hero Routine KIT
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Routine injection (no topical spray)
Trial: 21658093
Drug: Suspension formulation
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Suspension formulation of omeprazole in 8.4% sodium bicarbonate
Trial: 21658093
Drug: MUPS® formulation
FDA approved: no
EMA approved: no
PMDA approved: no
Description: MUPS® formulation of omeprazole disintegrated in water
Trial: 10930970
Drug: Intervention group
RxNorm normalized name: Streptococcus viridans group
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intervention group (medicine review and education programme)
Trial: 10930970
Drug: Intervention group
RxNorm normalized name: Streptococcus viridans group
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intervention group (medicine education)
Trial: 8222684
Drug: Selective digestive
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Selective digestive decontamination (oral antibiotics: polymyxin E, tobramycin, and amphotericin B)
Trial: 28065465
Drug: Gefitinib plus
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Gefitinib plus metformin
Trial: 29030864
Drug: Diclofenac sodium
RxNorm normalized name: Diclofenac Sodium
DrugBank: Diclofenac (DB00586)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Diclofenac sodium 3% gel
Trial: 18412566
Drug: Aged and
RxNorm normalized name: AGS-499
DrugBank: AGS-499 (DB18058)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Aged and menopaused receiving hormonal replacement therapy
Trial: 14594941
Drug: Chemotherapy with
RxNorm normalized name: Primatene with ephedrine Pill
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Chemotherapy with supportive care to control non-hematological adverse events (nausea/vomiting, anorexia, diarrhea)
Trial: 10919591
Drug: Mycophenolate mofetil
RxNorm normalized name: Mycophenolate Mofetil
DrugBank: Mycophenolate mofetil (DB00688)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Mycophenolate mofetil (MMF) 1 g twice daily (n=34)
Trial: 10919591
Drug: Azathioprine (AZA)
RxNorm normalized name: Azathioprine
DrugBank: Azathioprine (DB00993)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Azathioprine (AZA) 2 mg/kg (n=30)
Trial: 10919591
Drug: Dose reduction
RxNorm normalized name: Rebetron Combination Package for Rebetol Dose Reduction, Intron A 6,000,000 UNT/ML Multi-Dose Vial / 42 Rebetol Capsules
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dose reduction of MMF to 500 mg twice daily
Trial: 10919591
Drug: Dose reduction
RxNorm normalized name: Rebetron Combination Package for Rebetol Dose Reduction, Intron A 6,000,000 UNT/ML Multi-Dose Vial / 42 Rebetol Capsules
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dose reduction of AZA to 1.0 mg/kg
Trial: 8160596
Drug: Optimal medical
RxNorm normalized name: Optima Plus
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Optimal medical therapy (amiodarone)
Trial: 3168726
Drug: Sorbinil (250
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sorbinil (250 mg/day)
Trial: 27978511
Drug: Daprodustat 4
RxNorm normalized name: daprodustat 4 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Daprodustat 4 mg
Trial: 27978511
Drug: Daprodustat 6
RxNorm normalized name: daprodustat 6 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Daprodustat 6 mg
Trial: 27978511
Drug: Daprodustat 8
RxNorm normalized name: daprodustat 8 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Daprodustat 8 mg
Trial: 27978511
Drug: Daprodustat 10
RxNorm normalized name: daprodustat
DrugBank: Daprodustat (DB11682)
FDA approved: no
EMA approved: no
PMDA approved: yes
Description: Daprodustat 10 mg
Trial: 27881458
Drug: High-dose (HD)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High-dose (HD) group: 2 + 2 mg 17B-estradiol/day orally
Trial: 27881458
Drug: Low-dose (LD)
RxNorm normalized name: ethinyl estradiol
DrugBank: Ethinylestradiol (DB00977)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Low-dose (LD) group: 2 mg 17B-estradiol/day orally and placebo
Trial: 27027075
Drug: Low-level laser
RxNorm normalized name: low-density polyethylene
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Low-level laser therapy (LLLT) with an 830 nm gallium-aluminum-arsenic laser at 30 mW
Trial: 19654505
Drug: d-amphetamine (2.5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: d-amphetamine (2.5 mg/70 kg)
Trial: 19654505
Drug: d-amphetamine (5.0
FDA approved: no
EMA approved: no
PMDA approved: no
Description: d-amphetamine (5.0 mg/70 kg)
Trial: 19654505
Drug: d-amphetamine (10.0
FDA approved: no
EMA approved: no
PMDA approved: no
Description: d-amphetamine (10.0 mg/70 kg)
Trial: 19654505
Drug: diazepam (2.5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: diazepam (2.5 mg/70 kg)
Trial: 19654505
Drug: diazepam (5.0
FDA approved: no
EMA approved: no
PMDA approved: no
Description: diazepam (5.0 mg/70 kg)
Trial: 19654505
Drug: diazepam (10.0
FDA approved: no
EMA approved: no
PMDA approved: no
Description: diazepam (10.0 mg/70 kg)
Trial: 2185814
Drug: 5% dextrose
RxNorm normalized name: LMD with 5% Dextrose
DrugBank: D-glucose (DB01914)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 5% dextrose water 10 ml kg‐1 orally about 4 h before operation
Trial: 2185814
Drug: No oral
RxNorm normalized name: Beano Oral Product
FDA approved: no
EMA approved: no
PMDA approved: no
Description: No oral intake after midnight (fasted group)
Trial: 286492
Drug: BCG-CWS and
RxNorm normalized name: Tice BCG
DrugBank: Bacillus calmette-guerin substrain tice live antigen (DB10343)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: BCG-CWS and chemotherapy as maintenance therapy
Trial: 286492
Drug: BCG-CWS therapy
RxNorm normalized name: Tice BCG
DrugBank: Bacillus calmette-guerin substrain tice live antigen (DB10343)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: BCG-CWS therapy
Trial: 23895984
Drug: Topical mitomycin
RxNorm normalized name: Mitomycin
DrugBank: Mitomycin (DB00305)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Topical mitomycin C (MMC) application
Trial: 22004765
Drug: Tanezumab 25
RxNorm normalized name: tanezumab
DrugBank: Tanezumab (DB12335)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Tanezumab 25 μg/kg
Trial: 22004765
Drug: Tanezumab 100
RxNorm normalized name: tanezumab
DrugBank: Tanezumab (DB12335)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Tanezumab 100 μg/kg
Trial: 15362523
Drug: Chinese traditional
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Chinese traditional medicine, indomethacin, and three kinds of antibacterial agents
Trial: 15362523
Drug: Chinese traditional
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Chinese traditional medicine and indomethacin only
Trial: 15362523
Drug: Antibacterial agents
RxNorm normalized name: Dermoplast Antibacterial
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Antibacterial agents
Trial: 11375357
Drug: Nateglinide (120
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nateglinide (120 mg before three meals daily, n = 51)
Trial: 11375357
Drug: Glyburide (5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Glyburide (5 mg q.d. titrated to 10 mg q.d. after 2 weeks, n = 50)
Trial: 9225934
Drug: Recombinant human
RxNorm normalized name: Recombinant human TNF
DrugBank: Etanercept (DB00005)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: Recombinant human erythropoietin (rHuEPO) 141 U/kg subcutaneously, 6 injections between Days -21 and -7, along with 200 mg of iron saccharose complex intravenously at each visit.
Trial: 9225934
Drug: Placebo, along
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo, along with 200 mg of iron saccharose complex intravenously at each visit.
Trial: 7943463
Drug: Low-dose TRH
RxNorm normalized name: ethinyl estradiol
DrugBank: Ethinylestradiol (DB00977)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Low-dose TRH (0.5 mg) administered 5 minutes after ECT session 3 or 4
Trial: 3148039
Drug: 10 days
RxNorm normalized name: AlleRx 10-day Dose Pack
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 10 days of intravenous nutrition
Trial: 30310698
Drug: DHA supplementation
FDA approved: no
EMA approved: no
PMDA approved: no
Description: DHA supplementation (1g nutraceutical formulation)
Trial: 21029154
Drug: Oral health-related
RxNorm normalized name: Healthy Mama Oral Product
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral health-related quality of life
Trial: 16178295
Drug: Standardised treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Standardised treatment only
Trial: 1463177
Drug: Propofol induction
RxNorm normalized name: Propofol
DrugBank: Propofol (DB00818)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Propofol induction (1.5-2.5 mg/kg)
Trial: 1463177
Drug: Additional propofol
RxNorm normalized name: Propofol
DrugBank: Propofol (DB00818)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Additional propofol (0.5 mg/kg/30s)
Trial: 29772833
Drug: High protein
RxNorm normalized name: Vital High Protein
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High protein human milk fortifier (HMF) providing 1.8 g protein per 100 mL expressed breast milk (EBM)
Trial: 29772833
Drug: Standard human
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Standard human milk fortifier (HMF) providing 1 g protein per 100 mL expressed breast milk (EBM)
Trial: 25376396
Drug: Low-dose behavioral
RxNorm normalized name: ethinyl estradiol
DrugBank: Ethinylestradiol (DB00977)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Low-dose behavioral treatment (16 sessions)
Trial: 25376396
Drug: Moderate-dose behavioral
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Moderate-dose behavioral treatment (32 sessions)
Trial: 25376396
Drug: High-dose behavioral
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High-dose behavioral treatment (48 sessions)
Trial: 23118302
Drug: Rosuvastatin therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Rosuvastatin therapy (20 mg/d) for 12 months
Trial: 17170721
Drug: High-dose methotrexate
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High-dose methotrexate (HD MTX) at 1.5 g/m(2)/2 weeks x 6 in Lower-risk group
Trial: 17170721
Drug: High-dose methotrexate
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High-dose methotrexate (HD MTX) at 8 g/m(2)/2 weeks x 4 in Intermediate-risk group
Trial: 17170721
Drug: Low-dose methotrexate
RxNorm normalized name: ethinyl estradiol
DrugBank: Ethinylestradiol (DB00977)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Low-dose methotrexate (LD MTX) at 25 mg/m(2)/week in Lower-risk group
Trial: 17170721
Drug: Low-dose methotrexate
RxNorm normalized name: ethinyl estradiol
DrugBank: Ethinylestradiol (DB00977)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Low-dose methotrexate (LD MTX) in Intermediate-risk group
Trial: 17170721
Drug: High-dose methotrexate
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High-dose methotrexate (HD MTX)
Trial: 24415567
Drug: Pregabalin 150
RxNorm normalized name: pregabalin 150 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pregabalin 150 mg/d
Trial: 11361045
Drug: Onion supplement
RxNorm normalized name: ONION
DrugBank: Onion (DB10548)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Onion supplement (100 mg quercetin)
Trial: 11361045
Drug: Quercetin‐4'‐O‐glucoside (100
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Quercetin‐4'‐O‐glucoside (100 mg quercetin)
Trial: 11361045
Drug: Buckwheat tea
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Buckwheat tea (200 mg quercetin)
Trial: 11361045
Drug: Quercetin‐3‐O‐rutinoside (200
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Quercetin‐3‐O‐rutinoside (200 mg quercetin)
Trial: 7805372
Drug: Low-dose combined
RxNorm normalized name: ethinyl estradiol
DrugBank: Ethinylestradiol (DB00977)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Low-dose combined oral contraceptives (OCs)
Trial: 3170454
Drug: Thioridazine high
RxNorm normalized name: Thioridazine
DrugBank: Thioridazine (DB00679)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Thioridazine high dose (2.50 mg/kg per day)
Trial: 3170454
Drug: Thioridazine low
RxNorm normalized name: Thioridazine
DrugBank: Thioridazine (DB00679)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Thioridazine low dose (1.25 mg/kg per day)
Trial: 3170454
Drug: Thioridazine (both
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Thioridazine (both doses)
Trial: 20564914
Drug: COPD concurrent
FDA approved: no
EMA approved: no
PMDA approved: no
Description: COPD concurrent with T2D
Trial: 18460663
Drug: Combination pill
RxNorm normalized name: combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination pill containing 2.5 mg of folic acid, 50 mg of vitamin B6, and 1 mg of vitamin B12
Trial: 16368822
Drug: Lidocaine 1.5
RxNorm normalized name: LIDOCAINE 1.5%/EPI 1:200000 INJ
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Lidocaine 1.5 mg/kg IV
Trial: 10602739
Drug: Oral fluoroquinolones
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral fluoroquinolones (general)
Trial: 8615305
Drug: Rotational atherectomy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Rotational atherectomy (RA) with adjunctive balloon angioplasty
Trial: 1730079
Drug: Desferrioxamine B
RxNorm normalized name: Deferrioxamine B
DrugBank: Deferoxamine (DB00746)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Desferrioxamine B (100 mg/kg per day by continuous 72‐hour subcutaneous infusions)
Trial: 6397729
Drug: L-5-HTP (100
FDA approved: no
EMA approved: no
PMDA approved: no
Description: L-5-HTP (100 mg/day)
Trial: 29529618
Drug: Systemic IV
RxNorm normalized name: Vaginal System
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Systemic IV administration of 1 g vancomycin
Trial: 20197425
Drug: LABA step‐up
FDA approved: no
EMA approved: no
PMDA approved: no
Description: LABA step‐up (100 microg of fluticasone plus 50 microg of a long‐acting beta‐agonist twice daily)
Trial: 20197425
Drug: LTRA step‐up
FDA approved: no
EMA approved: no
PMDA approved: no
Description: LTRA step‐up (100 microg of fluticasone twice daily plus 5 or 10 mg of a leukotriene‐receptor antagonist daily)
Trial: 20197425
Drug: ICS step‐up
FDA approved: no
EMA approved: no
PMDA approved: no
Description: ICS step‐up (250 microg of fluticasone twice daily)
Trial: 1345826
Drug: Fine-bore silicone
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fine-bore silicone catheter (23 G, 15 cm)
Trial: 1345826
Drug: Teflon catheter
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Teflon catheter (20 G, 3.2 cm)
Trial: 6234505
Drug: Megavitamin therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Megavitamin therapy (3 g of niacinamide, 1.2 g of calcium pantothenate, 0.6 g of pyridoxine, and ascorbic acid)
Trial: 6234505
Drug: Megavitamin therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Megavitamin therapy
Trial: 31152740
Drug: Pantoprazole (40
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pantoprazole (40 mg daily)
Trial: 23873118
Drug: Dexmedetomidine (0.1,
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dexmedetomidine (0.1, 0.15, and 0.15 mcg/kg)
Trial: 18278193
Drug: Clopidogrel 600
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Clopidogrel 600 mg loading dose (LD) followed by 75 mg/d maintenance dose (MD) for 10 days
Trial: 18278193
Drug: Prasugrel 60
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Prasugrel 60 mg LD followed by 10 mg/d MD for 10 days
Trial: 18278193
Drug: Prasugrel 10
RxNorm normalized name: prasugrel 10 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Prasugrel 10 mg/d MD for 11 days
Trial: 29502548
Drug: THC (10
FDA approved: no
EMA approved: no
PMDA approved: no
Description: THC (10 mg) administered orally
Trial: 28641153
Drug: Rosuvastatin 40
RxNorm normalized name: rosuvastatin 40 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Rosuvastatin 40 mg for 24 months
Trial: 28641153
Drug: Atorvastatin 80
RxNorm normalized name: atorvastatin 80 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Atorvastatin 80 mg for 24 months
Trial: 20601740
Drug: Bovine colostrum
RxNorm normalized name: Bovine Colostrum
DrugBank: Bos taurus colostrum (DB19249)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Bovine colostrum (BC) 25 g per day for 10 weeks
Trial: 16282947
Drug: palivizumab (Synagis)
RxNorm normalized name: palivizumab Injection [Synagis]
DrugBank: Palivizumab (DB00110)
FDA approved: yes
EMA approved: yes
PMDA approved: no
Description: palivizumab (Synagis) 15 mg/kg, 5 monthly doses
Trial: 8535541
Drug: Nifedipine SR
RxNorm normalized name: Nifedipine
DrugBank: Nifedipine (DB01115)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Nifedipine SR monotherapy
Trial: 1966794
Drug: Low-molecular-weight heparin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Low-molecular-weight heparin (LMWH), subcutaneous injection once daily
Trial: 1966794
Drug: Placebo, subcutaneous
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo, subcutaneous injection once daily
Trial: 22036858
Drug: Compliance with
RxNorm normalized name: Primatene with ephedrine Pill
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Compliance with treatment guidelines (damage control, transfusions, mechanical ventilation)
Trial: 17326544
Drug: Follow-up after
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Follow-up after 18 months of therapy
Trial: 16858169
Drug: Terbinafine 500
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Terbinafine 500 mg/d orally for 7 days
Trial: 16858169
Drug: Itraconazole 200
RxNorm normalized name: itraconazole 200 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Itraconazole 200 mg/d orally for 7 days
Trial: 16858169
Drug: Fluconazole 150
RxNorm normalized name: fluconazole 150 MG
DrugBank: Fluconazole (DB00196)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Fluconazole 150 mg orally as a single dose
Trial: 8563868
Drug: Controlled-release mesalazine
RxNorm normalized name: mesalamine Delayed Release Oral Tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Controlled-release mesalazine (1500 mg/day)
Trial: 8563868
Drug: Sulfasalazine (3000
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sulfasalazine (3000 mg/day)
Trial: 2539714
Drug: Enalapril (20
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Enalapril (20 or 40 mg once daily)
Trial: 778569
Drug: Dihydergot (1.0
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dihydergot (1.0 mg i.m.)
Trial: 31041805
Drug: Elastic band
RxNorm normalized name: elastic bandage
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Elastic band training programme (twice a week for 8 weeks)
Trial: 26037632
Drug: 450 ml
RxNorm normalized name: ALCOHOL 270 mL in 450 mL EXTRACORPOREAL GEL
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 450 ml beetroot juice (5.5 mmol nitrate)
Trial: 22817699
Drug: Transdermal tulobuterol
RxNorm normalized name: tulobuterol
DrugBank: Tulobuterol (DB12248)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Transdermal tulobuterol patch (TP; 2 mg, once a day)
Trial: 22817699
Drug: Inhaled salmeterol
RxNorm normalized name: salmeterol Inhalant Product
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Inhaled salmeterol (50 µg, twice a day)
Trial: 18344636
Drug: Transdermal tulobuterol
RxNorm normalized name: tulobuterol
DrugBank: Tulobuterol (DB12248)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Transdermal tulobuterol patch (TP)
Trial: 20108779
Drug: Adefovir dipivoxil
RxNorm normalized name: Adefovir Dipivoxil
DrugBank: Adefovir dipivoxil (DB00718)
FDA approved: yes
EMA approved: yes
PMDA approved: no
Description: Adefovir dipivoxil 10 mg daily + Bicyclol 150 mg daily for 48 weeks
Trial: 20108779
Drug: Adefovir dipivoxil
RxNorm normalized name: Adefovir Dipivoxil
DrugBank: Adefovir dipivoxil (DB00718)
FDA approved: yes
EMA approved: yes
PMDA approved: no
Description: Adefovir dipivoxil 10 mg daily alone for 48 weeks
Trial: 16452737
Drug: DepoDur 20
RxNorm normalized name: DepoDur 20mg/2ml Extended-Release Suspension for Injection
FDA approved: no
EMA approved: no
PMDA approved: no
Description: DepoDur 20 mg
Trial: 16452737
Drug: DepoDur 30
RxNorm normalized name: morphine sulfate liposomal Injection [Depodur]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: DepoDur 30 mg
Trial: 16452737
Drug: Sham epidural
RxNorm normalized name: epidermal growth factor
DrugBank: Nepidermin (DB14145)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sham epidural injection
Trial: 15283931
Drug: Hormone Replacement
RxNorm normalized name: Parathyroid Hormone
DrugBank: Parathyroid hormone (DB05829)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Hormone Replacement Therapy (HRT) containing 2 mg 17‐beta estradiol plus 1 mg norethisterone acetate daily for 6 months
Trial: 12713610
Drug: 500 mg
RxNorm normalized name: bran 500 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 500 mg ornidazole vaginal ovules (VO)
Trial: 12713610
Drug: 500 mg
RxNorm normalized name: bran 500 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 500 mg ornidazole vaginal tablets (VT)